LAG3 and hepatitis A virus infection: Another potential LAG-3 ligand is LSECtin (liver and lymph node sinusoidal endothelial cell C-type lectin), whose expression in hepatic cells is inhibited upon LAG-3 binding, resulting in cytotoxic T-cell antiviral activity in murine models of hepatitis [16, 17].